116 related articles for article (PubMed ID: 38817702)
1. Considerations for the treatment of frail multiple myeloma patients.
Mohty M; Rajkumar SV
Clin Hematol Int; 2024; 6(1):23-25. PubMed ID: 38817702
[No Abstract] [Full Text] [Related]
2. Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients.
Djebbari F; Rampotas A; Panitsas F; Lim WY; Lees C; Tsagkaraki I; Gomes AR; Prideaux S; Chen L; Prodger C; Khera A; Gray N; Ellis L; Sangha G; Eyre TA; Moore S; Kothari J; Ramasamy K
PLoS One; 2022; 17(1):e0262388. PubMed ID: 35015781
[TBL] [Abstract][Full Text] [Related]
3. More intensive therapy as more effective treatment for frail patients with multiple myeloma [corrected].
DuMontier C; La J; Bihn J; Corrigan J; Yildirim C; Dharne M; Hassan H; Yellapragada S; Abel GA; Gaziano JM; Do NV; Brophy M; Kim DH; Munshi NC; Fillmore NR; Driver JA
Blood Adv; 2023 Oct; 7(20):6275-6284. PubMed ID: 37582048
[TBL] [Abstract][Full Text] [Related]
4. Elderly patients with multiple myeloma: towards a frailty approach?
Zweegman S; Engelhardt M; Larocca A;
Curr Opin Oncol; 2017 Sep; 29(5):315-321. PubMed ID: 28763310
[TBL] [Abstract][Full Text] [Related]
5. Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma.
Davis JA; Dima D; Ahmed N; DeJarnette S; McGuirk J; Jia X; Raza S; Khouri J; Valent J; Anwer F; Abdallah AO; Hashmi H
Transplant Cell Ther; 2024 Mar; 30(3):298-305. PubMed ID: 38142943
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone.
Lee HS; Kim K; Lee JJ; Yoon SS; Bang SM; Kim JS; Eom HS; Yoon DH; Lee Y; Shin HJ; Park Y; Jo JC; Lee WS; Do YR; Mun YC; Lee MH; Kim HJ; Kim SH; Kim MK; Lim SN; Park SK; Yi JH; Lee JH; Min CK;
Int J Hematol; 2021 Jan; 113(1):81-91. PubMed ID: 32889695
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported frailty phenotype (PRFP) vs. International Myeloma Working Group frailty index (IMWG FI) proxy: A comparison between two approaches to measuring frailty.
Murugappan MN; King-Kallimanis BL; Bhatnagar V; Kanapuru B; Farley JF; Seifert RD; Stenehjem DD; Chen TY; Horodniceanu EG; Kluetz PG
J Geriatr Oncol; 2024 Mar; 15(2):101681. PubMed ID: 38104480
[TBL] [Abstract][Full Text] [Related]
8. Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.
Efficace F; Gaidano G; Petrucci MT; Niscola P; Cottone F; Codeluppi K; Antonioli E; Tafuri A; Larocca A; Potenza L; Fozza C; Pastore D; Rigolin GM; Offidani M; Romano A; Kyriakou C; Cascavilla N; Gozzetti A; Derudas D; Vignetti M; Cavo M
Lancet Healthy Longev; 2022 Sep; 3(9):e628-e635. PubMed ID: 36102777
[TBL] [Abstract][Full Text] [Related]
9. Frail Multiple Myeloma Patients Deserve More Than Just a Score.
Miller HL; Sharpley FA
Hematol Rep; 2023 Feb; 15(1):151-156. PubMed ID: 36975728
[TBL] [Abstract][Full Text] [Related]
10. Electronic FRAIL score may predict treatment outcomes in older adults with myeloma.
Chan H; Chong YH; Seow MY; Li J; Garg P; Kelly M; Neylon A; McDiarmid B; Tan S; Jackson S
J Geriatr Oncol; 2021 May; 12(4):515-520. PubMed ID: 33046409
[TBL] [Abstract][Full Text] [Related]
11. A comparison of three different approaches to defining frailty in older patients with multiple myeloma.
Isaacs A; Fiala M; Tuchman S; Wildes TM
J Geriatr Oncol; 2020 Mar; 11(2):311-315. PubMed ID: 31326393
[TBL] [Abstract][Full Text] [Related]
12. The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review.
Mian H; McCurdy A; Giri S; Grant S; Rochwerg B; Winks E; Rosko AE; Engelhardt M; Pawlyn C; Cook G; Jackson G; Bringhen S; Facon T; Larocca A; Zweegman S; Wildes TM
Blood Cancer J; 2023 Jan; 13(1):6. PubMed ID: 36599867
[TBL] [Abstract][Full Text] [Related]
13. Treatment of older adult or frail patients with multiple myeloma.
Grant SJ; Freeman CL; Rosko AE
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):46-54. PubMed ID: 34889397
[TBL] [Abstract][Full Text] [Related]
14. Personalized Treatment of Multiple Myeloma in Frail Patients.
Lipof JJ; Abdallah N; Lipe B
Curr Oncol Rep; 2024 May; ():. PubMed ID: 38761302
[TBL] [Abstract][Full Text] [Related]
15. Special Considerations for Supportive Care and Management of Complications in Elderly Patients With Multiple Myeloma.
George LL; Malik MN; Miller EJ; Hicks K; Khanam R; Saterehaseman A; McNichol M; Anwer F
Clin Lymphoma Myeloma Leuk; 2021 Dec; 21(12):812-822. PubMed ID: 34384735
[TBL] [Abstract][Full Text] [Related]
16. Performance of the International Myeloma Working Group myeloma frailty score among patients 75 and older.
Murillo A; Cronin AM; Laubach JP; Hshieh TT; Tanasijevic AM; Richardson PG; Driver JA; Abel GA
J Geriatr Oncol; 2019 May; 10(3):486-489. PubMed ID: 30472368
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Frailty Scores in Newly Diagnosed Patients with Multiple Myeloma: A Review.
Mian H; Brouwers M; Kouroukis CT; Wildes TM
J Frailty Aging; 2019; 8(4):215-221. PubMed ID: 31637409
[TBL] [Abstract][Full Text] [Related]
18. Telehealth exercise to Improve Physical function and frailty in patients with multiple myeloma treated with autologous hematopoietic Stem cell transplantation (TIPS): protocol of a randomized controlled trial.
Lee K; Nathwani N; Shamunee J; Lindenfeld L; Wong FL; Krishnan A; Armenian S
Trials; 2022 Nov; 23(1):921. PubMed ID: 36329525
[TBL] [Abstract][Full Text] [Related]
19. A simplified frailty scale predicts outcomes in transplant-ineligible patients with newly diagnosed multiple myeloma treated in the FIRST (MM-020) trial.
Facon T; Dimopoulos MA; Meuleman N; Belch A; Mohty M; Chen WM; Kim K; Zamagni E; Rodriguez-Otero P; Renwick W; Rose C; Tempescul A; Boyle E; Manier S; Attal M; Moreau P; Macro M; Leleu X; Lorraine Chretien M; Ludwig H; Guo S; Sturniolo M; Tinel A; Silvia Monzini M; Costa B; Houck V; Hulin C; Yves Mary J
Leukemia; 2020 Jan; 34(1):224-233. PubMed ID: 31427722
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma Patients.
Bonello F; Boccadoro M; Larocca A
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33114320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
